Peptide Aptamers Expressed in the Secretory Pathway Interfere with Cellular PrPSc Formation

Journal of Molecular Biology

Volumn 371, Issue 2, 2007, Pages 362-373

  Gilch, Sabine ^a   Kehler, Claudia ^a   Schätzl, Hermann M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

peptide aptamers; prion prophylaxis; prion protein; prion therapy; secretory pathway

Indexed keywords

LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PEPTIDE APTAMER; PHOSPHATIDYLINOSITOL; PRION PROTEIN; SIGNAL PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ESCHERICHIA COLI; EUKARYOTIC CELL; IC 50; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; TWO HYBRID SYSTEM; YEAST;

ESCHERICHIA COLI; EUKARYOTA; MURINAE;

EID: 34447274298     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.05.052     Document Type: Article

References (54)

1. Colas P., Cohen B., Jessen T., Grishina I., McCoy J., and Brent R. Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature 380 (1996) 548-550
2. Hoppe-Seyler F., Crnkovic-Mertens I., Tomai E., and Butz K. Peptide aptamers: specific inhibitors of protein function. Curr. Mol. Med. 4 (2004) 529-538
3. Ladner R.C. Constrained peptides as binding entities. Trends Biotechnol. 13 (1995) 426-430
4. Famulok M., and Verma S. In vivo-applied functional RNAs as tools in proteomics and genomics research. Trends Biotechnol. 20 (2002) 462-466
5. Hoppe-Seyler F., Crnkovic-Mertens I., Denk C., Fitscher B.A., Klevenz B., Tomai E., and Butz K. Peptide aptamers: new tools to study protein interactions. J. Steroid Biochem. Mol. Biol. 78 (2001) 105-111
6. Geyer C.R., Colman-Lerner A., and Brent R. "Mutagenesis" by peptide aptamers identifies genetic network members and pathway connections. Proc. Natl Acad. Sci. USA 96 (1999) 8567-8572
7. Baines I.C., and Colas P. Peptide aptamers as guides for small-molecule drug discovery. Drug Discov. Today 11 (2006) 334-341
8. Peelle B., Lorens J., Li W., Bogenberger J., Payan D.G., and Anderson D.C. Intracellular protein scaffold-mediated display of random peptide libraries for phenotypic screens in mammalian cells. Chem. Biol. 8 (2001) 521-534
9. Nord K., Gunneriusson E., Ringdahl J., Stahl S., Uhlen M., and Nygren P.A. Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain. Nat. Biotechnol. 15 (1997) 772-777
10. Beste G., Schmidt F.S., Stibora T., and Skerra A. Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold. Proc. Natl Acad. Sci. USA 96 (1999) 1898-1903
11. Butz K., Denk C., Fitscher B., Crnkovic-Mertens I., Ullmann A., Schroder C.H., and Hoppe-Seyler F. Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity. Oncogene 20 (2001) 6579-6586
12. Butz K., Denk C., Ullmann A., Scheffner M., and Hoppe-Seyler F. Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein. Proc. Natl Acad. Sci. USA 97 (2000) 6693-6697
13. Buerger C., Nagel-Wolfrum K., Kunz C., Wittig I., Butz K., Hoppe-Seyler F., and Groner B. Sequence-specific peptide aptamers, interacting with the intracellular domain of the epidermal growth factor receptor, interfere with Stat3 activation and inhibit the growth of tumor cells. J. Biol. Chem. 278 (2003) 37610-37621
14. Nauenburg S., Zwerschke W., and Jansen-Durr P. Induction of apoptosis in cervical carcinoma cells by peptide aptamers that bind to the HPV-16 E7 oncoprotein. FASEB J. 15 (2001) 592-594
15. Colas P., Cohen B., Ko F.P., Silver P.A., and Brent R. Targeted modification and transportation of cellular proteins. Proc. Natl Acad. Sci. USA 97 (2000) 13720-13725
16. Kretzschmar H.A., Prusiner S.B., Stowring L.E., and DeArmond S.J. Scrapie prion proteins are synthesized in neurons. Am. J. Pathol. 122 (1986) 1-5
17. Nunziante M., Gilch S., and Schatzl H.M. Prion diseases: from molecular biology to intervention strategies. Chembiochem 4 (2003) 1268-1284
18. Prusiner S.B. Prions. Proc. Natl Acad. Sci. USA 95 (1998) 13363-13383
19. Weissmann C. Molecular biology of transmissible spongiform encephalopathies. Prog. Brain Res. 105 (1995) 15-22
20. Aguzzi A., and Polymenidou M. Mammalian prion biology: one century of evolving concepts. Cell 116 (2004) 313-327
21. Watts J.C., Balachandran A., and Westaway D. The expanding universe of prion diseases. PLoS Pathog. 2 (2006) e26
22. Bueler H., Aguzzi A., Sailer A., Greiner R.A., Autenried P., Aguet M., and Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell 73 (1993) 1339-1347
23. Riek R., Hornemann S., Wider G., Billeter M., Glockshuber R., and Wuthrich K. NMR structure of the mouse prion protein domain PrP(121-321). Nature 382 (1996) 180-182
24. Prusiner S.B. Novel structure and genetics of prions causing neurodegeneration in humans and animals. Biologicals 18 (1990) 247-262
25. Come J.H., Fraser P.E., and Lansbury Jr. P.T. A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc. Natl Acad. Sci. USA 90 (1993) 5959-5963
26. Caughey B., Race R.E., Ernst D., Buchmeier M.J., and Chesebro B. Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J. Virol. 63 (1989) 175-181
27. Taraboulos A., Scott M., Semenov A., Avrahami D., Laszlo L., and Prusiner S.B. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J. Cell Biol. 129 (1995) 121-132
28. Gilch S., Kehler C., and Schatzl H.M. The prion protein requires cholesterol for cell surface localization. Mol. Cell Neurosci. 31 (2006) 346-353
29. Marella M., Lehmann S., Grassi J., and Chabry J. Filipin prevents pathological prion protein accumulation by reducing endocytosis and inducing cellular PrP release. J. Biol. Chem. 277 (2002) 25457-25464
30. Mange A., Nishida N., Milhavet O., McMahon H.E., Casanova D., and Lehmann S. Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures. J. Virol. 74 (2000) 3135-3140
31. Gilch S., Winklhofer K.F., Groschup M.H., Nunziante M., Lucassen R., Spielhaupter C., et al. Intracellular re-routing of prion protein prevents propagation of PrP(Sc) and delays onset of prion disease. EMBO J. 20 (2001) 3957-3966
32. Ertmer A., Gilch S., Yun S.W., Flechsig E., Klebl B., Stein-Gerlach M., et al. The tyrosine kinase inhibitor STI571 induces cellular clearance of PrPSc in prion-infected cells. J. Biol. Chem. 279 (2004) 41918-41927
33. Chabry J., Caughey B., and Chesebro B. Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides. J. Biol. Chem. 273 (1998) 13203-13207
34. Proske D., Gilch S., Wopfner F., Schatzl H.M., Winnacker E.L., and Famulok M. Prion-protein-specific aptamer reduces PrPSc formation. Chembiochem. 3 (2002) 717-725
35. Enari M., Flechsig E., and Weissmann C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl Acad. Sci. USA 98 (2001) 9295-9299
36. Peretz D., Williamson R.A., Kaneko K., Vergara J., Leclerc E., Schmitt-Ulms G., et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412 (2001) 739-743
37. Feraudet C., Morel N., Simon S., Volland H., Frobert Y., Creminon C., et al. Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J. Biol. Chem. 280 (2005) 11247-11258
38. Perrier V., Solassol J., Crozet C., Frobert Y., Mourton-Gilles C., Grassi J., and Lehmann S. Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation. J. Neurochem. 89 (2004) 454-463
39. Gilch S., Wopfner F., Renner-Muller I., Kremmer E., Bauer C., Wolf E., et al. Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion-infected cells. J. Biol. Chem. 278 (2003) 18524-18531
40. Donofrio G., Heppner F.L., Polymenidou M., Musahl C., and Aguzzi A. Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies. J. Virol. 79 (2005) 8330-8338
41. Cardinale A., Filesi I., Vetrugno V., Pocchiari M., Sy M.S., and Biocca S. Trapping prion protein in the endoplasmic reticulum impairs PrPC maturation and prevents PrPSc accumulation. J. Biol. Chem. 280 (2005) 685-694
42. Vetrugno V., Cardinale A., Filesi I., Mattei S., Sy M.S., Pocchiari M., and Biocca S. KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity. Biochem. Biophys. Res. Commun. 338 (2005) 1791-1797
43. White A.R., Enever P., Tayebi M., Mushens R., Linehan J., Brandner S., et al. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422 (2003) 80-83
44. Solforosi L., Criado J.R., McGavern D.B., Wirz S., Sanchez-Alavez M., Sugama S., et al. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303 (2004) 1514-1516
45. Moroncini G., Kanu N., Solforosi L., Abalos G., Telling G.C., Head M., et al. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc. Proc. Natl Acad. Sci. USA 101 (2004) 10404-10409
46. Bogan A.A., and Thorn K.S. Anatomy of hot spots in protein interfaces. J. Mol. Biol. 280 (1998) 1-9
47. Sillerud L.O., and Larson R.S. Design and structure of peptide and peptidomimetic antagonists of protein-protein interaction. Curr. Protein Pept. Sci. 6 (2005) 151-169
48. Cattaneo A., and Biocca S. The selection of intracellular antibodies. Trends Biotechnol. 17 (1999) 115-121
49. Caspi S., Halimi M., Yanai A., Sasson S.B., Taraboulos A., and Gabizon R. The anti-prion activity of Congo red. Putative mechanism. J. Biol. Chem. 273 (1998) 3484-3489
50. Tatzelt J., Prusiner S.B., and Welch W.J. Chemical chaperones interfere with the formation of scrapie prion protein. EMBO J. 15 (1996) 6363-6373
51. Ermolenko D.N., Zherdev A.V., and Dzantiev B.B. Antibodies as specific chaperones. Biochemistry (Mosc.) 69 (2004) 1233-1238
52. Spielhaupter C., and Schatzl H.M. PrPC directly interacts with proteins involved in signaling pathways. J. Biol. Chem. 276 (2001) 44604-44612
53. Butler D.A., Scott M.R., Bockman J.M., Borchelt D.R., Taraboulos A., Hsiao K.K., et al. Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J. Virol. 62 (1988) 1558-1564
54. Vorberg I., Raines A., and Priola S.A. Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro. J. Biol. Chem. 279 (2004) 29218-29225